首页> 外文期刊>American pharmaceutical review >USP <643> Total Organic Carbon Recent Changes – FAQs
【24h】

USP <643> Total Organic Carbon Recent Changes – FAQs

机译:USP <643>总有机碳近期变化 - 常见问题解答

获取原文
获取原文并翻译 | 示例
           

摘要

The United States Pharmacopeia (USP) specifies regulations for pharmaceutical manufacturing and testing to ensure safe and effective drug products. USP Total Organic Carbon (TOC) pertains to requirements for testing pharmaceutical grade water. TOC is an important quality attribute that contributes to understanding water quality before use in critical applications. TOC is central to process control and patient safety and therefore stringent testing requirements are enforced by regulatory bodies around the world. USP <643> was revised effective May 2021 to require packaged water to have container volume-dependent TOC limits and system suitability concentrations. Whether using the Sievers M9, or another instrument for TOC analysis, now is the time to scrutinize technology and processes used to test TOC. Below are a few frequently asked questions regarding the recent USP <643> changes.
机译:None

著录项

  • 来源
    《American pharmaceutical review》 |2021年第4期|共2页
  • 作者

    Michelle Neumeyer;

  • 作者单位

    Life Sciences Product Applications Specialist for the Sievers line of analytical instruments SUEZ;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号